SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193805-23-000220
Filing Date
2023-02-14
Accepted
2023-02-14 16:31:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 e618265_sc13g-cp.htm SC 13G 53580
  Complete submission text file 0001193805-23-000220.txt   55218
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80136 | Film No.: 23630236
SIC: 2834 Pharmaceutical Preparations

Mailing Address 590 MADISON AVENUE 23RD FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 23RD FLOOR NEW YORK NY 10022 212-832-0900
Schonfeld Strategic Advisors LLC (Filed by) CIK: 0001665241 (see all company filings)

IRS No.: 475082310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G